Free Trial

Crescent Capital BDC (CCAP) Competitors

Crescent Capital BDC logo
$14.70 +0.13 (+0.89%)
As of 04:00 PM Eastern

CCAP vs. OXLC, USA, GAB, NUV, RVT, STEW, BCAT, CET, GSBD, and MFIC

Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include Oxford Lane Capital (OXLC), Liberty All-Star Equity Fund (USA), The Gabelli Equity Trust (GAB), Nuveen Municipal Value Fund (NUV), Royce Value Trust (RVT), SRH Total Return Fund (STEW), BlackRock Capital Allocation Term Trust (BCAT), Central Securities (CET), Goldman Sachs BDC (GSBD), and MidCap Financial Investment (MFIC). These companies are all part of the "financial services" industry.

Crescent Capital BDC vs. Its Competitors

Oxford Lane Capital (NASDAQ:OXLC) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Crescent Capital BDC has a net margin of 37.32% compared to Oxford Lane Capital's net margin of 0.00%. Crescent Capital BDC's return on equity of 11.90% beat Oxford Lane Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford Lane CapitalN/A N/A N/A
Crescent Capital BDC 37.32%11.90%5.40%

6.7% of Oxford Lane Capital shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 3.4% of Oxford Lane Capital shares are held by company insiders. Comparatively, 1.1% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Oxford Lane Capital received 162 more outperform votes than Crescent Capital BDC when rated by MarketBeat users. Likewise, 58.81% of users gave Oxford Lane Capital an outperform vote while only 52.24% of users gave Crescent Capital BDC an outperform vote.

CompanyUnderperformOutperform
Oxford Lane CapitalOutperform Votes
197
58.81%
Underperform Votes
138
41.19%
Crescent Capital BDCOutperform Votes
35
52.24%
Underperform Votes
32
47.76%

Oxford Lane Capital has higher earnings, but lower revenue than Crescent Capital BDC. Oxford Lane Capital is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford Lane Capital$57.31M34.56$376.14M$0.835.27
Crescent Capital BDC$60.50M9.00$83.84M$1.3410.97

In the previous week, Oxford Lane Capital and Oxford Lane Capital both had 3 articles in the media. Crescent Capital BDC's average media sentiment score of 1.30 beat Oxford Lane Capital's score of 0.96 indicating that Crescent Capital BDC is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxford Lane Capital
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Crescent Capital BDC
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Crescent Capital BDC has a consensus price target of $17.60, suggesting a potential upside of 19.73%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Oxford Lane Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxford Lane Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Crescent Capital BDC
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Oxford Lane Capital pays an annual dividend of $1.08 per share and has a dividend yield of 24.7%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 11.4%. Oxford Lane Capital pays out 130.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 125.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years.

Oxford Lane Capital has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500.

Summary

Crescent Capital BDC beats Oxford Lane Capital on 13 of the 20 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCAP vs. The Competition

MetricCrescent Capital BDCNondepository credit institutions IndustryFinance SectorNASDAQ Exchange
Market Cap$544.78M$8.13B$11.73B$8.62B
Dividend Yield11.40%4.34%5.66%4.17%
P/E Ratio7.3921.5823.0519.96
Price / Sales9.007.5826.86157.63
Price / Cash8.5542.1517.6034.64
Price / Book0.743.152.894.69
Net Income$83.84M$524.65M$1.04B$248.14M
7 Day Performance-0.27%3.78%1.53%2.39%
1 Month Performance-10.42%5.86%1.45%6.05%
1 Year Performance-21.01%21.78%540.37%13.60%

Crescent Capital BDC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCAP
Crescent Capital BDC
3.2806 of 5 stars
$14.70
+0.9%
$17.60
+19.7%
-22.0%$544.78M$60.50M7.39N/APositive News
Dividend Announcement
High Trading Volume
OXLC
Oxford Lane Capital
1.9002 of 5 stars
$4.50
+0.2%
N/A-20.3%$2.04B$57.31M5.42601Short Interest ↓
USA
Liberty All-Star Equity Fund
N/A$6.74
-0.1%
N/A+0.1%$1.82B$259.99M0.00N/A
GAB
The Gabelli Equity Trust
N/A$5.83
+0.6%
N/A+5.9%$1.79B$203.01M0.00N/APositive News
Short Interest ↓
NUV
Nuveen Municipal Value Fund
N/A$8.56
+0.2%
N/A+1.4%$1.78B$200.53M0.00640
RVT
Royce Value Trust
N/A$15.16
+0.7%
N/A+4.5%$1.75B$9.80M0.0050Short Interest ↑
Gap Down
STEW
SRH Total Return Fund
N/A$17.53
+0.5%
N/A+19.8%$1.69B$550.34M0.00N/ANews Coverage
Positive News
BCAT
BlackRock Capital Allocation Term Trust
N/A$15.23
+0.1%
N/A-9.0%$1.64B$197.67M0.00147,000Positive News
Short Interest ↓
CET
Central Securities
N/A$47.56
+0.4%
N/A+8.2%$1.38B$296.20M0.006Positive News
GSBD
Goldman Sachs BDC
1.4522 of 5 stars
$11.60
+0.8%
$12.00
+3.4%
-24.1%$1.36B$67.93M16.57N/APositive News
MFIC
MidCap Financial Investment
2.2767 of 5 stars
$13.09
+0.1%
$14.00
+7.0%
-17.3%$1.22B$113.46M8.39N/AShort Interest ↑

Related Companies and Tools


This page (NASDAQ:CCAP) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners